Management of Childhood Obesity

Hoda Gad1, Hajar Dauleh2, Idris Mohammed2

  • 1Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5T 3H7, Canada.

Insights

Childhood obesity involves excess fat accumulation, impacting health and quality of life. Management requires a multidisciplinary approach, including lifestyle changes and targeted therapies based on genetic causes for effective treatment.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Obesity is defined as excess adipose tissue accumulation, linked to metabolic and cardiac issues.
  • Numerous factors contribute to obesity, including genetics, environment, and behavior.
  • Obesity is associated with severe complications like diabetes, hypertension, and liver disease.

Purpose of the Study:

  • To provide a comprehensive review of current childhood obesity management strategies.
  • To highlight the importance of a patient-centered, multidisciplinary approach.
  • To emphasize precision-guided therapy based on genetic etiology.

Main Methods:

  • Literature review of current research on obesity management.
  • Analysis of contributing factors and associated complications.
  • Classification of childhood obesity causes (polygenic, monogenic, syndromic, endocrine).

Main Results:

  • Obesity management requires integrating lifestyle changes with pharmacotherapy and surgery.
  • Identifying genetic causes enables tailored and more effective treatments.
  • A multidisciplinary approach is crucial for patient-centered care.

Conclusions:

  • Effective childhood obesity management necessitates a personalized, multidisciplinary strategy.
  • Understanding genetic underpinnings allows for precision medicine in treating obesity.
  • This review synthesizes state-of-the-art approaches for pediatric obesity care.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
657